Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_2
2
17%
Ph phase_4
7
58%
Ph phase_3
2
17%

Phase Distribution

0

Early Stage

2

Mid Stage

9

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
7(63.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(4)
Terminated(3)
Other(3)

Detailed Status

Completed4
unknown3
Not yet recruiting2
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (18.2%)
Phase 32 (18.2%)
Phase 47 (63.6%)

Trials by Status

withdrawn18%
not_yet_recruiting217%
terminated217%
completed433%
unknown325%

Recent Activity

0 active trials
Showing 5 of 12
not_yet_recruitingphase_3

ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure

NCT00610051
not_yet_recruitingphase_4

Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke

NCT03252626
terminatedphase_2

PGE1 as Additive Anticoagulant in ECMO-Therapy

NCT02895373
unknownphase_4

Alprostadil as an Adjuvant Therapy With Indirect Angiosomal Revascularization in Critical Limb Ischemia.

NCT04312555
completedphase_4

Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP

NCT03296670
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT00610051Phase 3

ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure

Not Yet Recruiting
NCT03252626Phase 4

Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke

Not Yet Recruiting
NCT02895373Phase 2

PGE1 as Additive Anticoagulant in ECMO-Therapy

Terminated
NCT04312555Phase 4

Alprostadil as an Adjuvant Therapy With Indirect Angiosomal Revascularization in Critical Limb Ischemia.

Unknown
NCT03296670Phase 4

Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP

Completed
NCT03892447Phase 4

The Comparative Effectiveness of Alprostadil,Sodium Ferulate and Dopamine in Pediatric Acute Kidney Injury

Unknown
NCT00544076Phase 3

ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer

Terminated
NCT03027219

Blood Flow Change After Free Flap Surgery in Diabetic Patients

Completed
NCT00596752Phase 4

Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV

Completed
NCT03252665Phase 4

Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI

Unknown
NCT02228850Phase 2

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Completed
NCT01776320Phase 4

Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction

Withdrawn

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12